Flyer

Health Science Journal

  • ISSN: 1791-809X
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

On A Case of Nephrotic Syndrome

La centralita Della medicina interna nella gestione del paziente ospedalizzato (Proceedings of XXI Congress FADOI Campania)
Italy 2022

Asti A*, De Rosa AR, Maglione B, Izzo F, Ruggiero B, Villani A, Paglia N, Martone A, Romano A, Russo S

Department of Internal Medicine, S. Paolo Hospital, ASL Napoli 1, Italy

Scientific Tracks Abstracts: Health Sci J

Abstract:

Patient G.R., 41 years old, comes to our observation for massive, imprinting edema, subcutaneous abdominal tissue edema and significant weight gain. In the medical history he refers hypertension in therapy with zofenopril and depressive syndrome in therapy with escitalopram; he also reports that this symptomatology began a couple of days after the administration of the Moderna Sars-Cov2 vaccine. Upon admission, laboratory tests show mild hyper Trans aminasemia (AST = 42 U / L ALT = 72 U / L), slight increase in cholesterol (205 mg / dl), normocytic anaemia (Hb = 10.6 g / dl) hypo-albuminemia (1.8 g / dl with total proteins 3.6 g / dl); urea, creatinine and serum electrolytes are normal. The 24-hour proteinuria is over 5 g. Echocardiogram and total body CT scan are negative. Replacement treatment begins with albumin plus intravenous diuretics which improve symptoms and blood-chemistry parameters and strongly reduce declining edema. The patient will then be managed at discharge by the nephrologist colleagues for renal biopsy and follow-up of the nephrotic syndrome. We wanted to disclose this clinical case, because there are many observations in the literature of cases of nephrotic syndrome and glomerulonephritis following administration of the Sars-Cov2 vaccine, under observation by the EMA.